INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![GettyImages-1350789406 covid]( "Enhancing Investigator Training And Communication During COVID-19")
Enhancing Investigator Training And Communication During COVID-19Centralizing all trial-related information, enabling seamless interaction and global team coordination through Scout Academy.
-
![GettyImages-1585068774 patient doctor, clinical trial, data]( "Reduce Patient And Site Burden Through Excellence In Trial Logistics")
Reduce Patient And Site Burden Through Excellence In Trial LogisticsWatch for an insightful webinar where you’ll explore the latest strategies and innovations for managing clinical trial operations with a focus on device provisioning and data workflows.
-
![GettyImages-487610898 Vendors]( "Mid-Study RTSM Migration: How To Switch Vendors Without Disrupting Your Trial")
Mid-Study RTSM Migration: How To Switch Vendors Without Disrupting Your TrialEvaluate the risks of staying with an underperforming RTSM provider versus the benefits of a mid-study transition. Modern migration tools now offer a secure path to protect trial data and timelines.
-
![GettyImages-545581230-lab-research-computer-tablet-teamwork]( "The Rise Of Targeted Modalities In Pharmaceutical Development")
The Rise Of Targeted Modalities In Pharmaceutical DevelopmentTargeted modalities are pushing the boundaries of technology and therapeutic effectiveness. Their potential to transform patient care depends on leveraging the right expertise, technologies, and partnerships.
-
How To Optimize CMC And Clinical Strategies For Injectable, Oral Peptide Drugs3/17/2025
Advances in peptide drug delivery have opened new opportunities for peptide drug products, with non-parenteral routes of administration — such as oral and nasal — now feasible.
-
Medable's Japanese Clinical Trial Exceeds FPI Date And eCOA Adherence3/10/2025
A top-10 global pharma company aimed to address eCOA adherence and patient enrollment challenges faced by clinical trial sites in Japan. Explore an initiative to enhance the patient and site experience.
-
ICON And Medable Drive 85% eConsent Adoption In U.S. Menopause Study4/1/2026
A site-focused strategy drove strong eConsent adoption in a complex women’s health study, showing how tailored training and hands-on support boost engagement and compliance.
-
Pay-By-Procedure Vs. Pay-By-Visit12/8/2025
Explore how a pay-by-procedure model can reshape site payments, enhance transparency, and reveal meaningful efficiencies across complex clinical trials.
-
Travel And Payment Services: A Patient's Journey12/5/2025
Streamline patient travel and payments in your clinical trials by implementing centralized, high-quality concierge services that reduce burdens, improve satisfaction, and boost study performance.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![iStock-1280184645-patient-masks-pandemic-doctor]( "Pandemic Response Assessment")
In the face of the COVID-19 pandemic, biopharmaceutical companies had to react quickly to develop and implement what were frequently large scale crisis response initiatives. Read how now is the time to assess the changes that were implemented and refine business continuity plans to ensure regulatory compliance, patient safety, and organizational preparedness now and into the future.
-
![EU Regulations, europe union flag-GettyImages-1175944437]( "Clinical Trial Regulations")
This essential guide walks through mastering the complex landscape of clinical trial regulations, providing a clear, practical breakdown of regulatory timelines, legal obligations, and more.
-
![teamwork collaboration data analysis-GettyImages-1473508651]( "Accelerating Biologics Through Development Milestones")
Whether you're aiming to run a pivotal trial or multiple studies, discover how Veristat's full-service support can drive your biologic therapies from inception to market success.
-
![Human Immune System GettyImages-1201363459]( "Immune Challenge Models For Early Drug Development")
Inflammation is a primary pathogenic process in a wide range of diseases, including rheumatoid arthritis, cardiovascular disease, oncology and neuropsychiatric disorders.
-
![Brain-Power-GettyImages-1130826731]( "Comprehensive Services CNS Drug Development")
Our approach is designed to optimize efficiency and accelerate timelines, resulting in up to 40% time savings throughout the early phases of your drug development journey.
